Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Acetyldigoxins

Known as: Acetyldigoxins [Chemical/Ingredient], Desglucolanatosides C, acetyldigoxin 
Alpha- or beta-acetyl derivatives of DIGOXIN or lanatoside C from Digitalis lanata. They are better absorbed and longer acting than digoxin and are… 
National Institutes of Health

Related topics

Related topics

18 relations

Narrower (9)

16-acetylgitoxinAQM 263Digoxin DidierGladixol N
Expand

Broader (3)

Anti-Arrhythmia AgentsCardiotonic AgentsEnzyme Inhibitors
In Bloodagonistsantagonists & inhibitorsaspects of radiation effects
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Prescribing potentially inappropriate medication (PIM) in Germany's elderly as indicated by the PRISCUS list. An analysis based on regional claims data
The aim of this study was to estimate the prevalence of potentially inappropriate medication (PIM) in the elderly as indicated by… 
Highly Cited
2012
Highly Cited
2012
Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS list.
BACKGROUND The PRISCUS list of potentially inappropriate medications (PIM) for the elderly was published in 2010 and is the first… 
2009
2009
Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1.
Cardiac glycosides inhibit the Na(+),K(+)-ATPase and are used for the treatment of symptomatic heart failure and atrial… 
2001
2001
P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin.
Digoxin is a drug with a narrow therapeutic index, which is substrate of the ATP-dependent efflux pump P-glycoprotein. Increased… 
Review
1996
Review
1996
A review of the clinical pharmacokinetics of meloxicam.
Meloxicam is a new preferential cyclooxygenase-2 (COX-2) inhibitor currently for the treatment of osteoarthritis and rheumatoid… 
  • table I
Highly Cited
1991
Highly Cited
1991
Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study
The risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs were estimated in a population… 
1985
1985
Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta‐acetyldigoxin
  • J. Kuhlmann
  • Clinical pharmacology and therapeutics
  • 1985
  • Corpus ID: 27110466
To determine whether nifedipine or diltiazem affect digoxin kinetics, glycoside plasma concentrations and renal excretion were… 
1982
1982
Separation of digoxin, digitoxin and their potential metabolites, impurities or degradation products by high-performance liquid chromatography.
1981
1981
Effects of cytostatic drugs on plasma level and renal excretion of β‐acetyldigoxin
Mucosal defects decrease digoxin absorption in patients with malabsorption syndromes. Since the intestinal mucosa can be damaged… 
1975
1975
[Bioavailability of beta-acetyldigoxin and digoxin (author's transl)].
  • H. Flasch
  • Klinische Wochenschrift
  • 1975
  • Corpus ID: 30270385
Five beta-acetyldigoxin and two digoxin preparations were given orally to eleven healthy volunteers. In a single dose crossover… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE